Next, the authors used the fusion protein of barnase (binds to Barstar) and DARPin9.29 (recognizes the HER2 oncomarker) for targeted self-assembly of modified magnetic nanoparticles on the cancer cell surface. The gene discussed is ERBB2; the disease is cancer.